Gina Mendoza * Task 3 * Due: October 1, 2012 * What Companies have Recently Filed Initial Public Offerings? 1. Explain how you found the one or two companies that interested you. Step 1: I followed the link you provided. www.ipocentral.com Step 2: I browsed some of the subcategories that Hoovers’ IPO Central provided. [For Example: IPO Pipeline, IPO Filing, IPO Performance, IPO Scorecard, Biggest First Days, Winners and Losers.] Step 3: I then selected the IPO Calendar that listed all of the up and coming public offerings. Here I selected my companies: GlobeImmune, Inc. and FleetMatics Group Limited. The reason I chose these companies was because in the past I have worked directly with FleetMatics and GlobeImmune, Inc. Also, I see potential in both of their products and services. 2. What kind of information is available for each company? Hoovers provided the following information for both companies: Company Information FleetMatics Group Limited
 Company Information Penthouse Suite, Block C, Cookstown Court
 Tallaght, Dublin, Ireland
 (866) 844-2235 http://www.fleetmatics.com Top 3 Competitors Masternaut Limited FleetBoss Global Positioning Solutions, Inc. Teletrac, Inc. GlobeImmune, Inc.
Company Information 1450 Infinite Dr.
 Louisville, CO, 80027 United States (303) 625-2700 http://www.globeimmune.com Top 3 Competitors Bristol-Myers Squibb Company Merck & Co., Inc. Dendreon Corporation Company Profiles FleetMatics Group Limited Company Profile With FleetMatics, drivers never need to answer "What's your 20?" from the home office again. FleetMatics provides GPS-based telemetry services used to track company vehicles. Its GPS fleet tracking devices, sold under the brands FleetMatics and SageQuest, keep tabs on vehicles' locations, fuel consumption, speed, mileage, and other criteria. FleetMatics counts more than 16,000 customers, primarily small and midsized businesses with fewer than 1,000 vehicles. While the company is headquartered in Ireland, it does the majority (85%) of its business in the US. Founded in 2004, FleetMatics filed a $100 million initial public offering in the US in 2012. GlobeImmune, Inc. Company Profile GlobeImmune would like to stop disease around the world. For now, it works on its proprietary Tarmogen method of stimulating cell-level immunity to cancer and other diseases. It has five cancer candidates targeting pancreatic, lung, colorectal, and thyroid cancers while the fifth addresses the metastasis mechanism in multiple tumors. GlobeImmune's current infectious disease candidates seek to permanently cure hepatitis B and C. The company, which produces its own products, works with Celgene and Gilead Sciences to develop and commercialize the cancer and infectious disease drugs, respectively. The company was formed in 1995 as Ceres Pharmaceutical, changed its name in 2001, and filed to go public in 2012.

Hoovers’ IPO Calendar FleetMatics Group Limited (FLTX) Barclays Capital Inc. | Telemetry & Telematics Services Providers | Week of Oct. 1 | 7.8/34.4 (23%) | $125.0 | $15.00 - $17.00 |

Name (Proposed Ticker)Lead Underwriter | Industry | Expected Date | Shares Offered/ Outstanding | Offering Amount1 | ExpectedRangeLow-High | GlobeImmune, Inc. (GBIM)Wells Fargo Securities, LLC | Biopharmaceuticals & Biotherapeutics Manufacturing | Week of Sept. 17 | 5.0/17.2(29%) | $60.0 | $11.00 - $13.00 |

FleetMatics Income Statement | 2011 | 2010 | Revenue | $92.317 | $64.69 | Gross Profit | $0 | $0 | Operating Income | $0 | $0 | Net Income | $2.869 | $-736 | Diluted EPS | $0 | $0 | GlobeImmune, Inc. Income Statement | 2011 | 2010 | 2009 | Revenue | $5.108 | $4.068 | $2.542 | Gross Profit | $0 | $0 | $0 | Operating Income | $0 | $0 | $0 | Net Income | $-13.725 |